Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2015		Jun. 30, 2014
Cash Flows from Operating Activities:
Net loss	$ (794,008)		$ (987,569)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	26,303		24,082
Stock-based compensation expense	126,369		255,227
Changes in operating assets and liabilities:
Prepaid expenses	42,077		24,877
Accounts payable and accounts payable – related parties	66,423		(37,087)
Accrued expenses and accrued expenses – related parties	40,037		5,827
Net Cash Used in Operating Activities	(492,799)		(714,643)
Cash Flows from Investing Activities:
Cost of registering patents	(12,932)		(18,170)
Net Cash Used in Investing Activities	(12,932)		(18,170)
Cash Flows from Financing Activities:
Principal payments on notes payable	(37,274)		(29,820)
Issuance of common stock for cash	546,000		1,049,250
Net Cash Provided by Financing Activities	508,726		1,019,430
Effect of Foreign Currency Exchange Rates	19,662		2,418
Net increase in cash	22,657		289,035
Cash as of beginning of the period	140,496	[1]	81,856
Cash as of end of the period	163,153		370,891
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid for interest	725		731
SUPPLEMENTAL DISCLOSURE OF NON-CASH FINANCING ACTIVITIES:
Financing of insurance policies	$ 37,392		$ 27,169

[1] The condensed consolidated balance sheet as of December 31, 2014 has been prepared using information from the audited consolidated balance sheet as of that date.